WILLIAM DONALD SCHAEFER, Governor                    Ch. 127

[(i)] 1. Were not subject to premarketing
approval for safety and effectiveness under the Federal Food,
Drug, and Cosmetic Act;

[(ii)] 2. Are manufactured by firms meeting the
requirements of that act;

[(iii)] 3. Are subject to pharmacopoeial
standards that are adequate to assure product quality; and

[(iv)] 4. Have been determined by the
Commissioner of Food and Drugs to meet any other requirements
necessary to assure therapeutic equivalence; and

[(3)] (III) May list any additional drug products
that are determined by the Department to meet requirements that
are adequate to assure product quality and therapeutic
equivalence.

(2) THE DEPARTMENT MAY REMOVE A DRUG PRODUCT FROM THE
FORMULARY, AFTER OPPORTUNITY FOR PUBLIC COMMENT, THAT THE
DEPARTMENT DETERMINES IS THERAPEUTICALLY NONEQUIVALENT OR HAS A
NEGATIVE PHYSICAL OR BIOLOGICAL EFFECT ON THE CONSUMER OF THAT
DRUG PRODUCT.

SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall
take effect July 1, 1988.

Approved May 2, 1988.

CHAPTER 127

(Senate Bill 188)

AN ACT concerning

Respiratory Care Practitioners

FOR the purpose of requiring the State Board of Medical Examiners
to adopt regulations concerning the training,
qualifications, certification, and regulation of respiratory
care practitioners; requiring the Board to define certain
terms; providing for qualification requirements for
certification by the Board; requiring that after a certain
date a person must be certified by the Board before the
person may practice respiratory care; providing for the
continuation of the right of certain persons to practice
respiratory care; providing that this Act does not limit the
right of an individual to practice certain health

- 2097 -